Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics

Area of Science:

• Microbiology
• Medicinal Chemistry
• Drug Discovery

Background:

• Antibiotic resistance is a growing global health threat, diminishing the effectiveness of existing treatments.
• Rifampicin resistance often arises from mutations in RNA polymerase, necessitating novel therapeutic strategies.
• Hybrid antibiotics, with dual targets, offer a promising approach to overcome or delay resistance development.

Purpose of the Study:

• To synthesize and evaluate novel semi-synthetic hybrid antibiotics by linking kanglemycin A (Kang A) with fluoroquinolones.
• To compare the antimicrobial activity of Kang A hybrids synthesized via different attachment points.
• To explore the potential of the Kang A scaffold in developing agents effective against drug-resistant bacteria.

Main Methods:

• Synthesis of semi-synthetic hybrid antibiotics by covalently linking kanglemycin A (Kang A) with various fluoroquinolones.
• Evaluation of antimicrobial activity against bacterial strains, including those resistant to Kang A.
• Comparison of hybrid compounds linked at the dimethyl succinic acid moiety versus the naphthoquinone ring system of Kang A.

Main Results:

• Several synthesized Kang A-fluoroquinolone hybrids demonstrated antimicrobial activity.
• Some hybrids were effective against bacteria exhibiting resistance to Kang A, indicating the partnered fluoroquinolone's efficacy.
• The attachment point on the Kang A molecule influenced the resulting hybrid's activity profile.

Conclusions:

• The Kang A scaffold presents a versatile platform for developing novel hybrid antibiotics.
• Semi-synthetic hybrids linking Kang A with fluoroquinolones show potential for combating antibiotic-resistant Gram-positive infections.
• Targeting different sites on the Kang A molecule can yield hybrids with distinct resistance-circumventing properties.